Search Within

Renier J Brentjens

Formats
  1. Meeting Abstract (149)
  2. Journal Article (125)
  3. Review (5)
  4. Editorial (3)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Adult Leukemia (286)
  2. Center for Hematologic Malignancies (286)
  3. Department of Medicine (286)
  4. GSK Faculty (286)
  5. Hematologic Malignancies Research (286)
  6. Hematologic Malignancies, Division of (286)

More Groups

People
  1. Michel Sadelain (116)
  2. Isabelle Riviere (111)
  3. Jae Park (105)
  4. Xiuyan Wang (66)
  5. Terence Purdon (60)
  6. Elizabeth Halton (48)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (17)
  5. 2020 (26)
  6. 2019 (28)

More Years

Publications
  1. Blood (74)
  2. Journal of Clinical Oncology (26)
  3. Molecular Therapy (21)
  4. Cancer Research (10)
  5. Biology of Blood and Marrow Transplantation (8)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Hematology (79)
  2. Nature Publishing Group (52)
  3. American Association for Cancer Research (29)
  4. American Society of Clinical Oncology (27)
  5. Elsevier Inc. (25)
  6. Cell Press (6)

More Publishers

Results (286)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
    Journal Article

    Jin, C. H.; Xia, J.; Rafiq, S.; Huang, X.; Hu, Z.; Zhou, X.; Brentjens, R. J.; Yang, Y. G.
    EBioMedicine (2019)

    Fulltext@MSK | Save
  • Interleukin-12 armored chimeric antigen receptor (CAR) T cells for heterogeneous antigen-expressing ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Seshan, V.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma
    Meeting Abstract

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T.; Ghoddusi, M.; Purdon, T. J.; Do, T.; Wang, X.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prediction of CAR T-related toxicities in R/R DLBCL patients treated with axicabtagene ciloleucel using point of care cytokine measurements
    Meeting Abstract

    Faramand, R.; Kotani, H.; Morrissey, D.; Yu, B.; Locke, F. L.; Jain, M. D.; Chavez, J. C.; Wang, X.; Mishra, A.; Bachmeier, C. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Neurotoxicity associated with CD19-specific chimeric antigen receptor T cell therapy for adult acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Li, D.; Senechal, B.; Purdon, T.; Halton, E.; Diamonte, C.; Sadelain, M.; more...
    Neurology (2018)

    Fulltext@MSK | Save